Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Preferred Stock Liabilities (2016)

Anaptysbio (ANAB) has disclosed Preferred Stock Liabilities for 1 consecutive years, with $6.5 million as the latest value for Q4 2016.

  • For the quarter ending Q4 2016, Preferred Stock Liabilities changed N/A year-over-year to $6.5 million, compared with a TTM value of $6.5 million through Dec 2016, changed N/A, and an annual FY2016 reading of $6.5 million, changed N/A over the prior year.
  • Preferred Stock Liabilities was $6.5 million for Q4 2016 at Anaptysbio.
  • Across five years, Preferred Stock Liabilities topped out at $6.5 million in Q4 2016 and bottomed at $6.5 million in Q4 2016.